In vitro susceptibilities of 185 penicillin-susceptible and -resistant pneumococci to WY-49605 (SUN/SY 5555), a new oral penem, compared with those to penicillin G, amoxicillin, amoxicillin-clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime, and cefdinir.

Samankaltaisia teoksia

• Activity of WY-49605 compared with those of amoxicillin, amoxicillin-clavulanate, imipenem, ciprofloxacin, cefaclor, cefpodoxime, cefuroxime, clindamycin, and metronidazole against 384 anaerobic bacteria.
  Tekijä: Spangler, S K, et al.
  Julkaistu: (1994)
• Comparative antimicrobial activities of the penem WY-49605 (SUN5555) against recent clinical isolates from five U.S. medical centers.
  Tekijä: Sewell, D, et al.
  Julkaistu: (1995)
• Susceptibilities of beta-lactamase-producing and -nonproducing ampicillin-resistant strains of Haemophilus influenzae to ceftibuten, cefaclor, cefuroxime, cefixime, cefotaxime, and amoxicillin-clavulanic acid.
  Tekijä: Barry, A L, et al.
  Julkaistu: (1993)
• Bactericidal activities of cefprozil, penicillin, cefaclor, cefixime, and loracarbef against penicillin-susceptible and -resistant Streptococcus pneumoniae in an in vitro pharmacodynamic infection model.
  Tekijä: Cappelletty, D M, et al.
  Julkaistu: (1996)
• Antibacterial activities of cefpodoxime, cefixime, and ceftriaxone.
  Tekijä: Knapp, C C, et al.
  Julkaistu: (1988)